Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Alessandro Busca, Jon Salmanton‐García, Francesco Marchesi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre–Cellular Therapy SARS-CoV-2 Infection
Ila Nimgaonkar, Leah H Yoke, Pavitra Roychoudhury, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 86-95
Closed Access | Times Cited: 9
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
Jon Salmanton‐García, Francesco Marchesi, Francesca Farina, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102553-102553
Open Access | Times Cited: 8
Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience
Wei Sheng Joshua Loke, Jean Rachel M. Catapia, Chai L. Low, et al.
Annals of the Academy of Medicine Singapore (2025) Vol. 54, Iss. 1, pp. 5-16
Open Access
Navigating Coronavirus Disease 2019 in Immunocompromised Populations
Majd Alsoubani, Jennifer Chow
Infectious Disease Clinics of North America (2025)
Closed Access
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis
Osama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, et al.
Bone Marrow Transplantation (2025)
Open Access
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy
María Stefania Infante, David Nemirovsky, Sean M. Devlin, et al.
Transplantation and Cellular Therapy (2023) Vol. 30, Iss. 1, pp. 116.e1-116.e12
Open Access | Times Cited: 12
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report
Serena Vita, Alessandra D’Abramo, Andrea Coppola, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Tobias Lahmer, Jon Salmanton‐García, Francesco Marchesi, et al.
Infection (2024) Vol. 52, Iss. 3, pp. 1125-1141
Open Access | Times Cited: 4
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
Giuseppe Rossi, Jon Salmanton‐García, Chiara Cattaneo, et al.
International Journal of Infectious Diseases (2023) Vol. 137, pp. 98-110
Open Access | Times Cited: 10
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton‐García, Nicola Sgherza, et al.
Hematological Oncology (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 9
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
Tzong‐Yow Wu, Wan-Ting Tsai, Kai-Hsiang Chen, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 3, pp. 403-413
Open Access | Times Cited: 2
COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics
Emily A. Rosen, Elizabeth M. Krantz, Denise J. McCulloch, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 11, pp. 1108.e1-1108.e11
Closed Access | Times Cited: 2
Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Ankit Mittal, Javier T Solera, Victor H. Ferreira, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 11, pp. 706.e1-706.e7
Open Access | Times Cited: 7
COVID‐19 in hematopoietic stem‐cell transplant recipients: A systematic review and meta‐analysis of clinical characteristics and outcomes
Bruno Azevedo Randi, Hermes Ryoiti Higashino, Vinícius Ponzio da Silva, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 6
Closed Access | Times Cited: 6
Updated COVID‐19 clearance time among patients with cancer in the Delta and Omicron waves
Zachary M. Avigan, Rodrigo Paredes, Leora Boussi, et al.
Cancer Medicine (2023) Vol. 12, Iss. 16, pp. 16869-16875
Open Access | Times Cited: 5
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis
Alexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer‐Ausch, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1534-1534
Open Access | Times Cited: 4
Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care
Courtney M. Rowan, Brenna LaBere, Cameron C. Young, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 2, pp. 395-404
Open Access
Severe acute respiratory syndrome coronavirus 2 infection in hematopoietic stem cell transplant recipients in Mexico City
Nancy Martínez-Rivera, Daniel Franco, Brenda L. Acosta‐Maldonado, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 4
Closed Access
COVID‐19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group
Ceyhun Bozkurt, Volkan Hazar, Barış Malbora, et al.
Pediatric Transplantation (2024) Vol. 28, Iss. 3
Closed Access
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection
Benjamin J. Lee, Pongthep Vittayawacharin, Shawn P. Griffin, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 8, pp. 816.e1-816.e10
Closed Access
COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation
Qi Wen, Ze Guo, Xiaohui Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
COVID-19 in the immunocompromised host
Eric D. Morrell, F. Linzee Mabrey, J Goodman, et al.
European Respiratory Society eBooks (2024)
Closed Access
Pulmonary complications of bone marrow transplantation
H. O’Brien, John Murray, Nina Orfali, et al.
Breathe (2024) Vol. 20, Iss. 3, pp. 240043-240043
Open Access
Infectious Disease Considerations in Chronic Graft-versus-Host Disease and Transplantation Survivors
David J. Epstein, Salman Otoukesh, Zainab Shahid, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 9, pp. S534-S547
Open Access
Page 1 - Next Page

Scroll to top